Bioceres Crop Solutions Corp

Análisis de la acción Bioceres Crop Solutions Corp (BIOX)

$0.410

+0.006 (+1.46%)Al cierre

Loading chart…
High
0.430
Open
0.404
VWAP
0.41
Vol
148.40K
Mkt Cap
675.55M
Low
0.400
Amount
61.32K
EV/EBITDA, TTM
0.00

Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.

AI analysis of Bioceres Crop Solutions Corp (BIOX)

sell

Bioceres Crop Solutions Corp (BIOX) is not a good buy right now due to significant financial challenges and declining performance metrics. The current price is $0.41, and the company has reported a staggering year-to-date change of -69.63%, indicating severe underperformance. Additionally, the company is facing ongoing litigation risks that could further impact its financial health, with a non-cash impairment loss of approximately $179 million. The gross margin has also dropped to 30.10% in the latest quarter, down from 46.67% in the previous quarter, reflecting worsening profitability. These factors suggest that the risks outweigh any potential upside at this time.

Métricas de valoración

The current forward P/E ratio for Bioceres Crop Solutions Corp (BIOX) is 14.99, compared to its 5-year average forward P/E of 22.30.

Forward P/E

Fair
5Y Average P/E
22.30
Current P/E
14.99
Sobrevalorada
34.88
Infravalorada
9.71

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
10.12
Current EV/EBITDA
0.00
Sobrevalorada
12.14
Infravalorada
8.09

Forward P/S

Strongly Undervalued
5Y Average P/S
1.34
Current P/S
0.00
Sobrevalorada
1.85
Infravalorada
0.82

Alphio AI Price Scenarios for BIOX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BIOX

$4.41

Precio del escenario

B

Base

Base · 50%BIOX

$4.26

Precio del escenario

B

Bear

Bear · 25%BIOX

$3.79

Precio del escenario

Whales holding BIOX

F

Fourth Sail Capital LP

+ HoldingBIOX

-5.89%

3M Return

Cronología de eventos

2026-05-11 (ET)

17:10:00

Bioceres Reports Q3 Revenue of $39.4M

2026-03-16 (ET)

08:10:00

Bioceres CEO Discusses Financial Challenges and Restructuring Plans

2025-09-23 (ET)

07:05:26

Bioceres and Colorado Wheat Research Foundation Collaborate on HB4 Wheat Commercialization

2025-09-09 (ET)

06:03:26

Bioceres announces Q4 revenue of $74.7M, falling short of consensus estimate of $110.08M

Noticias

BIOX FAQ — answered by Alphio AI

Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops. It operates in the Basic Materials sector.

Bioceres Crop Solutions Corp (BIOX) is not a good buy right now due to significant financial challenges and declining performance metrics. The current price is $0.41, and the company has reported a staggering year-to-date change of -69.63%, indicating severe underperformance. Additionally, the company is facing ongoing litigation risks that could further impact its financial health, with a non-cash impairment loss of approximately $179 million. The gross margin has also dropped to 30.10% in the latest quarter, down from 46.67% in the previous quarter, reflecting worsening profitability. These factors suggest that the risks outweigh any potential upside at this time.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis